系统性红斑狼疮妊娠计划中缓解与低疾病活动度是否理想目标:多中心研究
该多中心前瞻性研究纳入281例SLE患者的347次妊娠,评估孕早期(<8周)达DORIS缓解或LLDAS与妊娠结局的关系。结果显示缓解或使用HCQ与较低疾病 flare 风险相关,HCQ与较低不良妊娠结局风险相关,完全缓解与APO风险降低接近显著。结论支持以疾病缓解为目标的孕前规划。
要点
- 孕早期达DORIS缓解或使用HCQ者妊娠期疾病 flare 风险更低。
- 有狼疮肾炎病史者妊娠期疾病 flare 风险增加。
- 使用HCQ与不良妊娠结局风险降低相关。
核心结论
- 以疾病缓解为明确治疗目标的孕前规划是降低SLE妊娠疾病 flare 和严重产科并发症风险的重要策略。
研究设计与样本
- 多中心前瞻性队列研究,纳入四个风湿病中心妊娠门诊监测的281例SLE患者的347次妊娠。
- 基线为妊娠8周前就诊时收集人口学和临床信息,包括是否达DORIS缓解和/或LLDAS。
主要发现
- 排除早期妊娠丢失后,212次妊娠(69.7%)基线处于缓解,33次(10.9%)处于LLDAS,其余为活动期。
- 多因素分析显示缓解或使用HCQ者疾病 flare 风险更低,有狼疮肾炎病史者风险增加。
- 不良妊娠结局风险在病程较短者中增加,使用HCQ为保护因素。
- 完全缓解与不良妊娠结局风险降低呈接近显著的关联。
关键数值与推荐
- 缓解采用DORIS标准,低疾病活动度采用LLDAS标准。
- 不良妊娠结局包括子痫前期、早产、小于胎龄儿、宫内生长受限和宫内胎死。
临床怎么用
- SLE患者孕前应以达到疾病缓解为目标进行规划,并考虑使用HCQ以降低 flare 和不良妊娠结局风险。
- 有狼疮肾炎病史者孕前需重点评估和监测 flare 风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine whether disease remission or low disease activity state at the beginning of pregnancy in SLE patients is associated with better pregnancy outcome. METHODS: Pregnancies in SLE patients prospectively monitored by pregnancy clinics at four rheumatology centres were enrolled. Patient demographics and clinical information were collected at baseline (pregnancy visit before 8 weeks of gestation) including whether patients were in remission according to the Definition of Remission in SLE (DORIS) criteria and and/or Lupus Low Disease Activity State (LLDAS). Univariate and multivariate analysis were performed to determine predictors of disease flare and adverse pregnancy outcomes (APOs) including preeclampsia, preterm delivery, small for gestational age infant, intrauterine growth restriction and intrauterine fetal death. RESULTS: A total of 347 pregnancies were observed in 281 SLE patients. Excluding early pregnancy losses, 212 pregnancies (69.7%) occurred in patients who were in remission at baseline, 33 (10.9%) in patients in LLDAS, and the remainder in active patients. Seventy-three flares (24%) were observed during pregnancy or puerperium, and 105 (34.5%) APOs occurred. Multivariate analysis revealed that patients in disease remission or taking HCQ were less likely to have disease flare, while a history of LN increased the risk. The risk of APOs was increased in patients with shorter disease duration, while being on HCQ resulted a protective variable. An almost significant association between complete remission and a decreased risk of APOs was observed. CONCLUSIONS: Prenatal planning with a firm treat-to-target goal of disease remission is an important strategy to reduce the risk of disease flares and severe obstetric complications in SLE pregnancies.
引用
- Tani C, Zucchi D, Haase I, et al. Are remission and low disease activity state ideal targets for pregnancy planning in systemic lupus erythematosus? A multicentre study. Rheumatology (Oxford). 2021. PMID: 33590843. doi:10.1093/rheumatology/keab155
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。